Falling into a deep dark hole: Tongan people's perceptions of being at risk of developing type 2 diabetes.
Pacific Island
Tonga
Type 2 Diabetes
prediabetes
risk perception
Journal
Health expectations : an international journal of public participation in health care and health policy
ISSN: 1369-7625
Titre abrégé: Health Expect
Pays: England
ID NLM: 9815926
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
05
01
2020
revised:
09
03
2020
accepted:
12
03
2020
pubmed:
23
5
2020
medline:
19
8
2021
entrez:
23
5
2020
Statut:
ppublish
Résumé
Prediabetes is a precursor for type 2 diabetes. Compared to the New Zealand/European and other population groups (24.6%), the prevalence of prediabetes is higher within Pacific groups (29.8%). The diagnosis of prediabetes presents a potential opportunity to intervene to prevent progression to type 2 diabetes. To develop an understanding of how being 'at risk' of developing type 2 diabetes is perceived by Tongan people with prediabetes living in Auckland, New Zealand. The Kakala and Talanga Tongan methodologies underpinned this study. Twelve one-on-one, semi-structured interviews with Tongan patients who had prediabetes from a primary health-care clinic in Auckland, New Zealand, were conducted. Thematic analysis was used to identify recurrent themes from the data. Participants were not aware of their prediabetes diagnosis, emotions associated with the diagnosis reflected fear and disbelief and a perception of imminent danger. Family history informed perceptions of the risk of developing type 2 diabetes. Participants could not differentiate prediabetes from type 2 diabetes, and recollections of being 'back in the Islands' of Tonga were consistent with healthy lifestyles. Prediabetes appeared to be poorly understood and was believed to be irreversible, which could discourage behaviour change, social and physical improvements in health. Appropriate culturally tailored messages to accompany a prediabetes diagnosis, including cause and management, would be beneficial for Pacific peoples.
Sections du résumé
BACKGROUND
Prediabetes is a precursor for type 2 diabetes. Compared to the New Zealand/European and other population groups (24.6%), the prevalence of prediabetes is higher within Pacific groups (29.8%). The diagnosis of prediabetes presents a potential opportunity to intervene to prevent progression to type 2 diabetes.
OBJECTIVE
To develop an understanding of how being 'at risk' of developing type 2 diabetes is perceived by Tongan people with prediabetes living in Auckland, New Zealand.
METHODS
The Kakala and Talanga Tongan methodologies underpinned this study. Twelve one-on-one, semi-structured interviews with Tongan patients who had prediabetes from a primary health-care clinic in Auckland, New Zealand, were conducted. Thematic analysis was used to identify recurrent themes from the data.
RESULTS
Participants were not aware of their prediabetes diagnosis, emotions associated with the diagnosis reflected fear and disbelief and a perception of imminent danger. Family history informed perceptions of the risk of developing type 2 diabetes. Participants could not differentiate prediabetes from type 2 diabetes, and recollections of being 'back in the Islands' of Tonga were consistent with healthy lifestyles.
CONCLUSIONS
Prediabetes appeared to be poorly understood and was believed to be irreversible, which could discourage behaviour change, social and physical improvements in health. Appropriate culturally tailored messages to accompany a prediabetes diagnosis, including cause and management, would be beneficial for Pacific peoples.
Identifiants
pubmed: 32441864
doi: 10.1111/hex.13056
pmc: PMC7495076
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
837-845Informations de copyright
© 2020 The Authors Health Expectations published by John Wiley & Sons Ltd.
Références
N Z Med J. 2013 Mar 01;126(1370):23-42
pubmed: 23474511
Am J Prev Med. 2015 Oct;49(4):512-9
pubmed: 26091928
Diabetes Care. 2006 Sep;29(9):2102-7
pubmed: 16936160
Nurs Times. 2014 Jun 25-Jul 1;110(26):24-6
pubmed: 25087268
Diabetes Care. 2009 Oct;32(10):1820-2
pubmed: 19592631
Health Soc Care Community. 2018 Nov;26(6):979-987
pubmed: 30074658
World J Diabetes. 2015 Mar 15;6(2):296-303
pubmed: 25789110
Diabetes Educ. 2019 Jun;45(3):302-314
pubmed: 31018784
BMC Health Serv Res. 2012 Dec 17;12:460
pubmed: 23241135
Diabet Med. 2007 Jul;24(7):770-7
pubmed: 17403125
Curr Diabetes Rev. 2015;11(4):261-72
pubmed: 25901500
N Z Med J. 2002 Apr 26;115(1152):194-6
pubmed: 12044005
Health Promot Pract. 2012 May;13(3):388-94
pubmed: 21971869
Diabetes Manag (Lond). 2011 Mar;1(2):191-199
pubmed: 21860659
Health Expect. 2019 Oct;22(5):1122-1131
pubmed: 31368649
Diabetes Care. 2016 Aug;39(8):1468-71
pubmed: 27457638
N Z Med J. 2004 Jan 30;117(1188):U743
pubmed: 14999303
Patient Educ Couns. 2008 Jul;72(1):88-93
pubmed: 18367365
Prev Med. 1999 Dec;29(6 Pt 1):563-70
pubmed: 10600438
Diabetes Educ. 2016 Dec;42(6):667-677
pubmed: 27621093
Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):65-70
pubmed: 15386815
N Z Med J. 2009 May 22;122(1295):28-37
pubmed: 19648984
Prim Care Diabetes. 2008 Dec;2(4):187-93
pubmed: 18996075
Med Clin North Am. 2011 Mar;95(2):341-52, viii
pubmed: 21281837
Am J Clin Nutr. 1991 Jun;53(6 Suppl):1647S-1651S
pubmed: 2031501
J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S108-13
pubmed: 12819313
Health Expect. 2020 Aug;23(4):837-845
pubmed: 32441864
Prev Med. 2016 Dec;93:7-13
pubmed: 27612580
Patient Educ Couns. 2019 Nov;102(11):2097-2101
pubmed: 31176557
J Cardiovasc Nurs. 2012 Nov-Dec;27(6):468-75
pubmed: 21912273
BMC Public Health. 2016 Aug 25;16(1):876
pubmed: 27557801
Diabetes. 1984 Jun;33(6):596-603
pubmed: 6373464